Pharmaceutical - Arena Pharmaceuticals, Research

Filter

Popular Filters

Arena Pharma licenses temanogrel to Ildong Pharma for South Korea

28-11-2012

The USA's Arena Pharmaceuticals (Nasdaq: ARNA) has entered into a co-development and license agreement…

Arena PharmaceuticalsAsia-PacificCardio-vascularIldong PharmaLicensingPharmaceuticalResearchtemanogrel

Arena files complete response on lorcaserin

05-01-2012

In another attempt to gain approval for its obesity drug candidate that was turned down by US regulators…

Arena PharmaceuticalsEisailorcaserinLorquessMetabolicsNorth AmericaPharmaceuticalRegulationResearch

Back to top